Ads

In a trial, Pfizer-BioNTech’s low-dose shot did not provoke an adequate immune response in 2- to 5-year-olds.


By BY APOORVA MANDAVILLI AND REBECCA ROBBINS from NYT World https://ift.tt/3sf8pnX
Share:

No comments:

Post a Comment

Labels

Blog Archive

Info

Ads

Recent Posts